In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Akero Therapeutics Inc (NASDAQ: AKRO) closed at $28.69 in the last session, up 1.59% from day before closing price of $28.24. In other words, the price has increased by $1.59 from its previous closing price. On the day, 0.51 million shares were traded. AKRO stock price reached its highest trading level at $29.1145 during the session, while it also had its lowest trading level at $27.85.
Ratios:
We take a closer look at AKRO’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 24.89 and its Current Ratio is at 24.89. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
On September 19, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $69.
On August 28, 2023, UBS started tracking the stock assigning a Buy rating and target price of $83.UBS initiated its Buy rating on August 28, 2023, with a $83 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Sep 20 ’24 when Yale Catriona sold 5,500 shares for $27.65 per share. The transaction valued at 152,086 led to the insider holds 75,294 shares of the business.
Yale Catriona sold 3,871 shares of AKRO for $106,685 on Sep 18 ’24. The Chief Development Officer now owns 75,294 shares after completing the transaction at $27.56 per share. On Sep 16 ’24, another insider, Yale Catriona, who serves as the Chief Development Officer of the company, sold 2,485 shares for $27.52 each. As a result, the insider received 68,375 and left with 75,294 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, AKRO now has a Market Capitalization of 1991969664 and an Enterprise Value of 1267687296.
Stock Price History:
Over the past 52 weeks, AKRO has reached a high of $51.24, while it has fallen to a 52-week low of $11.25. The 50-Day Moving Average of the stock is 8.51%, while the 200-Day Moving Average is calculated to be 20.93%.
Shares Statistics:
According to the various share statistics, AKRO traded on average about 625.37K shares per day over the past 3-months and 610730 shares per day over the past 10 days. A total of 69.43M shares are outstanding, with a floating share count of 58.09M. Insiders hold about 16.33% of the company’s shares, while institutions hold 98.57% stake in the company. Shares short for AKRO as of 1726185600 were 7163232 with a Short Ratio of 11.45, compared to 1723680000 on 7193443. Therefore, it implies a Short% of Shares Outstanding of 7163232 and a Short% of Float of 10.620000000000001.
